BOLALARDA PNEVMONIYANI DAVOLASHDA PEKTOLVAN C NI ISHLATISH

TO'LIQ MATN:

Abstrakt

Kirish. Bolalardagi pnevmoniya pediatriyaning eng dolzarb muammolaridan biri bo'lib qolmoqda, chunki u bolalar, ayniqsa yosh bolalar o'limining asosiy sabablaridan biridir. Har yili dunyo bo'ylab, ayniqsa, tibbiy yordam ko'rsatish darajasi past bo'lgan mamlakatlarda bolalarda pnevmoniyaning millionlab holatlari qayd etiladi va jiddiy asoratlarni (plevrit, nafas olish etishmovchiligi) keltirib chiqarishi mumkin. Pnevmoniyaga turli mikroorganizmlar (viruslar, bakteriyalar, zamburug'lar) sabab bo'lishi mumkin, bu esa diagnostika va davolashni murakkablashtiradi. Bundan tashqari, antibiotiklarga bakterial qarshilik kuchaymoqda, bu esa terapiyaning samarasini kamaytiradi. Diagnostik muammolar - yosh bolalarda pnevmoniya belgilari nozik bo'lishi mumkin, bu o'z vaqtida tashxis qo'yishni qiyinlashtiradi va davolanishni kechiktirish xavfini oshiradi. Bolalardagi pnevmoniya kasalxonaga yotqizishning eng ko'p uchraydigan sabablaridan biri bo'lib, qalin balg'amni tozalashda qiyinchiliklardan kelib chiqqan nafas olish buzilishi belgilari bilan tavsiflanadi. Tadqiqot maqsadi: bolalarda pnevmoniyani davolashda Pectolvan C dan foydalanish samaradorligini baholash. Materiallar va usullar: Tez tibbiy shoshilinch yordam ilmiy markazi Samarqand filialining pediatriya bo‘limiga yotqizilgan 4-12 yoshli 54 nafar bemor terapiyasiga qarab ikki guruhga bo‘lingan. Asosiy guruh (27 bola) yoshga mos dozada Pectolvan C qo'shilishi bilan murakkab davolanishni oldi. Nazorat guruhi (27 bemor) faqat standart kompleks terapiya oldi. Natijalar va xulosalar: Pectolvan C ning samaradorligi 10 kun davomida ikkala guruhdagi bemorlarning ahvoli dinamikasini solishtirish orqali baholandi. Natijalar Pectolvan C pnevmoniyani davolash uchun mukolitik va ekspektoran xususiyatlarga ega samarali kombinatsiyalangan vosita ekanligini ko'rsatdi. Foydalanish qulayligi, suyuq shaklning mavjudligi va nojo'ya ta'sirlarning yo'qligi ushbu preparatni nafas yo'llarining yallig'lanish kasalliklarini davolashda pediatrik amaliyotda keng qo'llash uchun tavsiya qilish imkonini beradi.

Mualliflar haqida

Adabiyotlar ro'yxati

Maidannik V.G., Mitin Yu.V. Diagnostics, treatment and prevention of inflammatory diseases of the respiratory system in children. - K.: IC Medprominfo, 2006. - 288 p.

Tatochenko V.K. Respiratory diseases in children. Practical guide. Ed. V.K. Tatochenko. Moscow: Pediatrician. 2012. 480 p. https://ambulatoria.net/download/Tatochenko_detskaya_pulmonologiya.pdf

Besh L.V., Matsyura O.I. Modern aspects of the choice of mucoactive cough therapy in pediatric practice Lviv National Medical University named after Danylo Halytsky, Lviv, Ukraine Lviv City Children's Allergology Center, Lviv, Ukraine Vol. 13, No. 6, 2018 565-569 https://cyberleninka.ru/article/n/sovremennye-aspekty-vybora-mukoaktivnoy-terapii-kashlya-v-pediatricheskoy-praktike

Ibragimova M.F., Shavazi N.M., Lim M.V., Ataeva M.S. Diagnostic and therapeutic methods for community-acquired pneumonia with atypical etiology in children. Vestnik Vrachei 2021, No. 4 (101), 29-32 https://inlibrary.uz/index.php/doctors_herald/article/view/1620

Tatochenko V.K. Practical pulmonology of childhood / ed. Tatochenko V.K. - Moscow: 2000. - 268 p.

Ibragimova, M. F. (2022). Use of the drug pectolvan c in the treatment of atypical pneumonia in children. Biology, 3, 136. http://pbim.uz/ru/article/887

Mamarizaev I. K. FEATURES OF THE COURSE, MORPHO-FUNCTIONAL AND CLINICAL-INSTRUMENTAL INDICATORS OF COMMUNITY-ACQUIRED PNEUMONIA WITH MYOCARDITIS IN CHILDREN // UZBEK MEDICAL JOURNAL. - 2024. - Vol. 5. - No. 2.

Tursunova, B., Urunova, M., & Ibragimova, M. (2023). Changes in the state of immunity at the cellular level in patients with bronchiolitis. International Journal of Scientific Pediatrics, 2(12), 428-430.https://ijsp.uz/index.php/journal/article/view/199

Fedorovna, I. M., & Ravshanovna, E. M. (2024). Optimization of treatment of atypical pneumonia due to hypoxic-ischemic encephalopathy in newborns. Research Focus, 3(1), 220-

https://cyberleninka.ru/article/n/optimization-of-treatment-of-atypical-pneumonia-due-to-hypoxic-ischemic-encephalopathy-in-newborns

Komilzhonovich M. I. OPTIMIZATION OF TREATMENT OF ATOPIC DERMATITIS IN CHILDREN //International journal of scientific researchers (IJSR) INDEXING. – 2024. – Т. 5. – №. 2. – С. 642-646

Fedorovna, I. M., & Kizi, S. Z. S. (2023). STATE OF HUMORAL IMMUNITY IN PATIENTS WITH ATYPICAL PNEUMONIA IN FREQUENTLY ILL CHILDREN. Research Focus, 2(10), 125-128. https://cyberleninka.ru/article/n/state-of-humoral-immunity-in-patients-with-atypical-pneumonia-in-frequently-ill-children

Qanday qilib iqtibos keltirish kerak

Ibragimova М. (2025). BOLALARDA PNEVMONIYANI DAVOLASHDA PEKTOLVAN C NI ISHLATISH. Xalqaro Ilmiy Pediatriya Jurnali, 4(2), 884–886. Retrieved from https://www.ijsp.uz/index.php/journal/article/view/318
Ko'rishlar soni: 0

Ushbu muallif(lar)ning eng koʻp oʻqilgan maqolalari